Dr Ed Day MA BM BCh DM MRCPsych

Dr Ed Day

School of Psychology
Clinical Reader in Addiction Psychiatry
Institute for Mental Health

Dr Ed Day is a Psychiatrist who combines clinical work in the NHS with research and teaching. He specializes in the treatment of drug and alcohol use disorders, and his research focuses on testing novel pharmacological and psychosocial interventions. He was appointed the National Recovery Champion by the Home Office in May 2019.

Learn more

Qualifications

MA, BM, BCh, DM, MRCPsych

Biography

Dr Ed Day trained as a psychiatrist on the West Midlands training scheme and completed an DM in addiction psychiatry at the University of Oxford. He was a Senior Clinical Lecturer in the Medical School at the University of Birmingham, before moving to the Addictions Department at the Institute of Psychiatry, Psychology and Neuroscience at King’s College London in 2013. He returned to Birmingham in April 2019 as a Clinical Reader in the Institute for Mental Health. He is a Consultant in Addiction Psychiatry with Birmingham & Solihull Mental Health NHS Foundation Trust, working in the Solihull Integrated Addiction Service (SIAS). He has been a member of expert advisory groups at the Department of Health, the National Institute for Health and Care Excellence (NICE), and Public Health England.

Teaching

Ed set up and ran an MSC program in the Treatment of Addictive Behaviours at the University of Birmingham between 2008 and 2012. He currently teaches about addictions-related issues on the DClinPsy, MBChB, and MPharm courses, and is developing a module on addictions and mental illness on the new Institute for Mental Health MSc program.

Research

Other activities

Executive member of the Society for the Study of Addiction (SSA) 2007-present, and currently the Vice-President.

Elected member of the Addictions Faculty at the Royal College of Psychiatry in 2018, and former Vice-Chair and Academic Secretary.

Appointed by the Home Office as the National Drug Recovery Champion in May 2019

Publications

Frew E, Goranitis I, Coast J, Day E, Copello A, Freemantle N, Seddon JL, Bennett C. Measuring health and broader well-being benefits in the context of opiate dependence: the psychometric performance of the ICECAP-A and the EQ-5D-5L. Value in Health. 2019; doi:10.1016/j.jval.2016.04.010

Strang J, Kelleher M, Mayet S, Day E, Hellier J, Byford S, Murphy C, McLennan B, Shearer J, Ryan E, Marsden J. Extended-release naltrexone versus standard oral naltrexone versus placebo for opioid use disorder: the NEAT three-arm RCT. Health Technol Assess. 2019;23(3)

O Emmerson, T Parkman, S Akhtar, E Lowe, E Day. 'You should be helping him, he's trying to do something about it': The dilemma of heroin use, agonist opioid treatment and employment. Heroin Addiction and Related Clinical Problems. 2018;20(6):17-25

Anderson BM, Dutton M, Day E, Jackson TA, Ferro CJ, Sharif A. Frailty Intervention Trial iN End-Stage patientS on haemodialysis (FITNESS): study protocol for a randomised controlled trial. Trials. 2018;19 (1), 457

Day E, Copello A, Seddon JL, Christie M, Bamber D, Powell C, Bennett C, Akhtar S, George S, Ball A, Frew E, Goranitis I, Freemantle N. A pilot feasibility randomised controlled trial of an adjunct brief social network intervention in opiate substitution treatment services. BMC Psychiatry. 2018;18(1):8.

Peak J, Goranitis I, Day E, Copello A, Freemantle N, Frew E. Predicting health-related quality of life (EQ-5D-5L) and capability wellbeing (ICECAP-A) in the context of opiate dependence using routine clinical outcome measures: CORE-OM, LDQ and TOP.  Health and Quality of Life Outcomes. 2018;16(1):106 https://doi.org/10.1186/s12955-018-0926-7

Day E. Commentary on Jones et al. An inconvenient truth—complex problems require complex solutions. Addiction. 2018;113(2):287-8.

Lowe E, Akhtar S, Emmerson O, Parkman T & Day E. The impact of employment on perceived recovery from opiate dependence. Drugs and Alcohol Today. 2018;18(4):206-216  https://doi.org/10.1108/DAT-12-2017-0062

Metrebian N, Weaver T, Pilling S, Hellier J, Byford S, Shearer J, Mitcheson L, Astbury M, Bijral P, Bogdan N, Bowden-Jones O, Day E, Dunn J, Finch E, Forshall S, Glasper A, Morse G, Akhtar S, Bajaria J, Bennett C, Bishop E, Charles V, Davey C, Desai R, Goodfellow C, Haque F, Little N, McKechnie H, Morris J, Mosler F, Mutz J, Pauli R, Poovendran D, Slater E, Strang J. Positive reinforcement targeting abstinence in substance misuse (PRAISe): Study protocol for a cluster RCT & process evaluation of contingency management. Contemporary Clinical Trials. 2018;71(8):124-132

Kalk NJ, Robertson JR, Kidd B, Day E, Kelleher MJ, Gilvarry E, et al. Treatment and Intervention for Opiate Dependence in the United Kingdom: Lessons from Triumph and Failure. European Journal on Criminal Policy and Research. 2018:24(2):183-200.

Bogdanowicz KM, Stewart R, Chang CK, Shetty H, Khondoker M, Day E, Hayes RD, Strang J. Excess overdose mortality immediately following transfer of patients and their care as well as after cessation of opioid substitution therapy. Addiction. 2018:113(5):946-951 https://doi.org/10.1111/add.14114

Zvauya R, Oyebode F, Day E, Thomas C, Jones L. A comparison of stress levels, coping styles and psychological morbidity between graduate-entry and traditional undergraduate medical students during the first 2 years at a UK medical school. BMC Research Notes. 2017;10(1):93.

Watson J, Toner P, Day E, Back D, Brady L-M, Fairhurst C, et al. Youth social behaviour and network therapy (Y-SBNT): adaptation of a family and social network intervention for young people who misuse alcohol and drugs – a randomised controlled feasibility trial. Health Technology Assessment. 2017;21(15).

Ratcliffe K, Chopra B, Day E. Understanding diversion of prescribed opioid agonist medications in Birmingham, UK - prevalence and predictors of diversion. Heroin Addiction & Related Clinical Problems. 2017;19(1):27-40.

Parkman T, Neale J, Day E, Drummond C. How Do People Who Frequently Attend Emergency Departments for Alcohol-Related Reasons Use, View, and Experience Specialist Addiction Services? Substance Use & Misuse. 2017;52(11):1460-1468.

Parkman T, Neale J, Day E, Drummond C. Qualitative exploration of why people repeatedly attend emergency departments for alcohol-related reasons. BMC Health Services Research. 2017;17(1):140.

Neale J, Parkman T, Day E, Drummond C. Socio-demographic characteristics and stereotyping of people who frequently attend accident and emergency departments for alcohol-related reasons: Qualitative study. Drugs: Education, Prevention and Policy. 2017;24(1):67-74.

Goranitis I, Coast J, Day E, Copello A, Freemantle N, Frew E. Maximizing health or sufficient capability in economic evaluation? A methodological experiment of treatment for drug addiction. Medical Decision Making. 2017;37(5):498-511.

Day E, Mitcheson L. Response to commentaries: Neither optimism or nihilism… but reasons for hope. Addiction. 2017: 112(8):1342–1344

Day E, Mitcheson L. Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism? Addiction. 2017: 112(8):1329–1336

Bhala N, Haroon S, Burwood S, Pennell C, Carter H, Daley A, Day E, El Sharkaway A, Ferguson J, Freshwater D, Gordon V, Holt A, Mittal A, Mukarati J, Perry I, Phillips A, Quann N, Tahir M, Thomson R, Unitt E, Bray C, Dennis N, Wrench G, and on behalf of the West Midlands Liver Health Collaborative Network. PTU-059 Burden of liver disease in the west midlands: increased premature mortality. Gut. 2017. http://dx.doi.org/10.1136/gutjnl-2017-314472.154

Bhala N, Haroon S, Burwood S, Pennell C, Carter H, Daley A, Day E, El Sharkaway A, Ferguson J, Freshwater D, Gordon V, Holt A, Mittal A, Mukarati J, Perry I, Phillips A, Quann N, Tahir M, Thomson R, Unitt E, Bray C, Dennis N, Wrench G, and on behalf of the West Midlands Liver Health Collaborative Network. PTU-060 Burden of liver disease in the west midlands: alcoholic liver disease hospital admissions increased. Gut. 2017 http://dx.doi.org/10.1136/gutjnl-2017-314472.155

Wilcox J, Waite C, Tomlinson L, Driscoll J, Karim A, Day E, Sharif A. Comparing glycaemic benefits of Active Versus passive lifestyle Intervention in kidney Allograft Recipients (CAVIAR): study protocol for a randomised controlled trial. Trials. 2016;17(1):417.

Strang J, McDonald R, Tas B, Day E. Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures? Addiction. 2016;111(4):574-82.

Sondhi A, Ryan G, Day E. Stakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England. Harm Reduction Journal. 2016;13(5).

Kidd B, Day E, Strang J. What matters is more than just the choice of pharmaceutical agent. Addiction. 2016;111(5):779-81.

Hull M, Day E. Identification and Management of Alcohol Use Disorders in the Community. Clinical Focus Primary Care. 2016;9(3):141-9.

Goranitis I, Coast J, Day E, Copello A, Freemantle N, Seddon J, Bennett C, Frew E. Measuring health and broader well-being benefits in the context of opiate dependence: the psychometric performance of the ICECAP-A and the EQ-5D-5L. Value in Health. 2016;19(6):820-8.

Drummond C, Gilburt H, Burns T, Copello A, Crawford M, Day E, Deluca P, Godfrey C, Parrott S, Rose A, Sinclair J, Coulton S. Assertive community treatment for people with alcohol dependence: a pilot randomized controlled trial. Alcohol and Alcoholism. 2016;52(2):234-41.

Chatters R, Cooper K, Day E, Knight M, Lagundoye O, Wong R, Kaltenthaler E. Psychological and psychosocial interventions for cannabis cessation in adults: A systematic review. Addiction Research & Theory. 2016;24(2):93-110.

Watson J, Back D, Toner P, Lloyd C, Day E, Brady L-M, Templeton L, Ambegaokar S, Parrott S, Torgerson D, Cocks K, McArdle P, Copello A. A randomised controlled feasibility trial of family and social network intervention for young people who misuse alcohol and drugs: study protocol (Y-SBNT). Pilot and Feasibility Studies. 2015;1(1):8.

Sondhi A, Day E. Factors that predict dissemination of evidence-based practice in one local authority in England: an assessment of introducing node-link mapping into substance misuse practice. Drugs: Education, Prevention and Policy. 2015;22(2):160-5.

Reed K, Day E, Keen J, Strang J. Pharmacological treatments for drug misuse and dependence. Expert Opinion on Pharmacotherapy. 2015;16(3):325-33.

Milward J, Day E, Wadsworth E, Strang J, Lynskey M. Mobile phone ownership, usage and readiness to use by patients in drug treatment. Drug and Alcohol Dependence. 2015;146:111-5.

Day E, Wall R, Chohan G, Seddon J. Perceptions of professional drug treatment staff in England about client barriers to narcotics anonymous attendance. Addiction Research & Theory. 2015;23(3):223-30.

Day E, Copello A, Hull M. Assessment and management of alcohol use disorders. BMJ. 2015;350:h715.

Wall R, Sondhi A, Day E. What influences referral to 12-step mutual self-help groups by treatment professionals? European Addiction Research. 2014;20(5):241-7.

Rees G, Day E. Addiction to prescription drugs. Prescriber. 2014;25(5):5-6.

Marsden J, Eastwood B, Ali R, Burkinshaw P, Chohan G, Copello A, Burn D, Kelleher M, Mitcheson L,  Taylor S, Wilson N, Whiteley C, Day E. Development of the addiction dimensions for assessment and personalised treatment (ADAPT). Drug and Alcohol Dependence. 2014;139:121-31.

Kihara R, Day E. Transient psychotic episodes following recreational use of NRG‐3. Progress in Neurology and Psychiatry. 2014;18(3):14-8.

Parker R, Armstrong MJ, Corbett C, Day EJ, Neuberger JM. Alcohol and substance abuse in solid-organ transplant recipients. Transplantation. 2013;96(12):1015-24.

Day E, Copello A, Seddon JL, Christie M, Bamber D, Powell C, et al. Pilot study of a social network intervention for heroin users in opiate substitution treatment: study protocol for a randomized controlled trial. Trials. 2013;14(1):264.

Day E, Copello A, Karia M, Roche J, Grewal P, George S, et al. Social network support for individuals receiving opiate substitution treatment and its association with treatment progress. European Addiction Research. 2013;19(4):211-21.

Day E, Bentham PW, Callaghan R, Kuruvilla T, George S. Thiamine for prevention and treatment of Wernicke‐Korsakoff Syndrome in people who abuse alcohol. Cochrane Database of Systematic Reviews, Issue 7, Art. No.: CD004033. Doi: 10.1002/14651858.CD004033.pub3

Copello A, Walsh K, Graham H, Tobin D, Griffith E, Day E, Birchwood M. A consultation-liaison service on integrated treatment: a program description. Journal of Dual Diagnosis. 2013;9(2):149-57.

Sondhi A, Day E. An assessment of SERVQUAL as a measure of service quality in English male prisons: Perceptions and expectations of the Integrated Drug Treatment System (IDTS). Drugs: Education, Prevention and Policy. 2012;19(2):171-80.

Lingford-Hughes AR, Welch S, Peters L, Nutt D, Ball D, Buntwal N, Chick J, Crome I, Daly C, Dar K, Day E, Duka T, Finch E, Law F, Marshall E, Munafo M, Myles J, Porter S, Raistrick D, Reed L, Reid A, Sell L, Sinclair J, Tyrer P, West R, Williams T, Winstock A. BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP. J Psychopharmacol 2012;26(7):899-952

 

Gilburt H, Burns T, Copello A, Coulton S, Crawford M, Day E, Deluca P, Godfrey C, Parrott S, Rose A, Sinclair J, Wright C & Drummond C. Assertive Community Treatment for Alcohol Dependence (ACTAD): Study Protocol for an Exploratory Randomised Controlled Trial. Trials. 2012;13:19.

Day E. Commentary on Schwartz et al. Methadone treatment as palliation or an individualized process of recovery management? Addiction, 2012;107(5): 953-

Day E. Commentary on Nosyk et al. detoxification from methadone maintenance therapy: how important is the exact technique that is used? Addiction. 2012;107(9):1630-1.

Copello A, Walsh K, Graham H, Tobin D, Fellows S, Griffith E, Day E, Birchwood M. The impact of training within a comprehensive dual diagnosis strategy: the Combined Psychosis and Substance Use (COMPASS) experience. Mental Health and Substance Use. 2012;5(3):206-16.

 

Best D, Groshkova T, Sadler J, Day E & White W. What is Recovery? Functioning and recovery stories of self-identified people in recovery in a services user group and their peer networks in Birmingham England. Alcoholism Treatment Quarterly. 2011;29(3): 293-313

 

Day E & Strang J. Outpatient versus inpatient opioid detoxification. A randomized controlled trial. Journal of Substance Abuse Treatment. 2011;40(1): 56-66

 

Best D, Groshkova T, Loaring J, Ghufran S, Day E & Taylor A. Comparing the addiction careers of heroin and alcohol users and their self-reported reasons for achieving abstinence. Journal of Groups in Addiction & Recovery. 2010;5(3): 289-305

 

Lopez Gaston R, Best D, Day E & White W. Perceptions of 12-step interventions among UK substance misuse patients attending residential in-patient treatment in a UK treatment setting. Journal of Groups in Addiction & Recovery. 2010;5(3): 306-323

 

Best D, Wood K, Sweeting R, Morgan B, Day E. Fitting a quart into a black box: Keyworking in quasi-coercive drug treatment in England. Drugs, Education, Prevention and Policy, 2010;17(4): 370-378

 

Day E, Callaghan R, Kuruvilla T, George S, Webb K & Bentham P. The impact of a pharmacy-led intervention on the management of Wernicke’s Encephalopathy. The Psychiatrist. 2010;24: 234-238

 

Gorring, H, Turner, E, Day, E, Vassilas, CA, Aynsley, M. A clinical librarian pilot project in psychiatry. The Psychiatrist. 2010;34: 65-68

 

Day E Maximising the treatment outcomes of opioid substitution treatment. Evidence Based Mental Health, 2010;13(1):5-7

 

Day E (Commentator) Review: Adding psychosocial interventions to pharmacotherapy for opioid detoxification improves outcomes. Evidence Based Mental Health, 2009;12(1):15

 

Best D, Day E, Morgan B, Oza T, Copello A, Gossop M. What treatment means in practice: an analysis of the delivery of evidence-based structured interventions in criminal justice drug treatment services in Birmingham, England. Addiction Research & Theory 2009;17(6): 678-687

 

Lopez Gaston R, Best D, Manning V & Day E. Can we prevent drug related deaths by training opioid users to recognise and manage overdoses? Harm Reduction Journal 2009;6:26  doi:10.1186/1477-7517-6-26

 

Smith A, Best D, Day E. Assessing non-injecting heroin use in Birmingham, UK: a comparison of characteristics and reasons for non-injection in samples of never-injected and formerly-injecting heroin users in contact with adult drug treatment. Journal of Drug Issues 2009;39(5):477-494

 

Clutterbuck R, Tobin D, Orford J, Copello A, Preece M, Birchwood M, Day E, Graham H, Griffith E, McGovern D. Exploring the attitudes of staff working within mental health settings toward clients who use cannabis. Drugs: Education, Prevention and Policy, 2009;16(4): 311-327

 

Day E, Best D, Sweeting R, Russell R, Webb K, Georgiou G & Neuberger J. Predictors of Psychological Morbidity in Liver Transplant Assessment Candidates: Is alcohol abuse or dependence a factor? Transplant International, 2009;22: 606-614

 

Best D, Segal J & Day E. Changing patterns of heroin and crack use during pregnancy and beyond. Journal of Substance Use, 2009;14(2) 124-132

 

Packer G, Best D, Day E, & Wood K (2009). Criminal thinking and self-control among drug users in court mandated treatment. Criminology & Criminal Justice, 2009;9(1) 69-86

 

Best D, Day E, Campbell A, Flynn, PM, Simpson DD. Relationship between drug treatment engagement and criminal thinking style among drug-using offenders. European Addiction Research, 2009;15(2) 71-77

 

Simpson D, Rowan-Szal G, Joe, G, Best D, Day E & Campbell A. Relating counsellor attributes to client engagement. Journal of Substance Abuse Treatment, 2009;36 313-320

 

Greaves A, Best D, Day E, & Foster A. Young people in coerced drug treatment: Does the UK Drug Intervention Programme provide a useful and effective service to young offenders? Addiction Research and Theory, 2009;17(1) 17-29

 

Best D, Ghufran S, Day E, Ray R, Loaring J. Breaking the habit: A retrospective analysis of desistance factors among formerly problematic heroin users. Drug and Alcohol Review, 2008;27(6) 619-624

 

Day E, Best D, Sweeting R, Russell R, Webb K, Georgiou G & Neuberger J. Detecting lifetime alcohol problems in individuals referred for liver transplantation for non-alcoholic liver failure. Liver Transplantation 2008;14: 1609-1613

 

Best D, Walker D, Foster A, Ellis-Gray S, & Day E. Gender differences in risk and treatment uptake in drug using offenders assessed in custody suite settings. Policing & Society, 2008;18(4) 474-485

 

Clutterbuck R, Tobin D, Orford J, Copello A, Birchwood M, Day E, Graham H, McGovern D, Griffith E. Staff attitude towards cocaine/crack-cocaine use amongst individuals with severe mental health problems in an inner city area of the UK. Mental Health & Substance Use: Dual Diagnosis, 2008;1(3) 205-215

 

Best D, Day E, Homayoun S, Lenton H, Moverley R, Openshaw M. Treatment Retention in the Drug Intervention Programme: Do Primary Drug Users Fare Better Than Primary Offenders. Drugs: Education, Prevention & Policy, 2008;15(2) 201-210

 

Best D, Day E, Cantillano V, Gaston R, Nambamali A, Sweeting R, Keaney F. Mapping heroin careers: Utilising a standardised history-taking method to assess the speed of escalation of heroin using careers in a treatment-seeking cohort. Drug and Alcohol Review, 2008;27(2) 165-170

 

Day E, Best D, Cantillano V, Gaston R, Nambamali A, Keaney F. Measuring the use and career histories of drug users in treatment: Reliability of the Lifetime Drug Use History (LDUH) and its data yield relative to clinical case notes. Drug and Alcohol Review, 2008;27(2) 171-177

 

Day E, Best D, Copello A, Young H, Khoosal N & Modern N. Characteristics of drug-using patients and treatment provided in primary and secondary settings. Journal of Substance Use 2008;13(1): 27-35

 

Day E & Furlong E. Reading about… self-help books on substance misuse. Psychiatric Bulletin, 2008;32(2): 78-79

 

Best D, Day E, McCarthy T, Darlington I, & Pinchbeck K. The Hierarchy of Needs and Care Planning in Addiction Services: What Maslow Can Tell Us About Addressing Competing Priorities? Addiction Research and Theory, 2008;16(4) 305-307

 

George S & Day E. Buprenorphine in the treatment of opioid dependence. British Journal of Hospital Medicine, 2007;68(11): 594-597

 

Rashid H, Ormerod S & Day E. Anabolic Androgenic Steroids: What the Psychiatrist Needs to Know. Advances in Psychiatric Treatment, 2007;13: 203-211

 

Day E & Best D. Natural history of substance-related problems. Psychiatry, 2007;6: 12-15

 

Williamson E, Smith M, Orford J, Copello A, Day E. Social Behaviour and Network Therapy for drug problems: Evidence of Benefits and Challenges. Addictive Disorders and Their Treatment 2007;6(4):167-179

 

Meier P, Best D, & Day E. Detoxification in Rehabilitation in England: Effective continuity of care or unhappy bedfellows? Journal of Substance Use, 2007;12(4) 293-300

 

Day E, Best D, George S & Copello A. Drug users’ experiences of prescribed injectable methadone: the impact on drug use and perceptions of stability. Journal of Drug Issues, 2007;37(2) 341-355

 

Best D, Day E, & Campbell A. Developing a Method for Conducting Needs Assessments for Drug Treatment: A Systems Approach Addiction, Research & Theory, 2007;15(3): 263-276

 

Connock M, Juarez-Garcia A, Jowett S, Frew E, Liu Z, Fry-Smith A, Day E, Linzeris N, Roberts T, Burls A, Taylor R. Methadone and Buprenorphine for the Management of Opioid Dependence: A Systematic Review and Economic Evaluation. Health Technology Assessment, 2006;11(9) 1-171

 

Adi Y, Juarez-Garcia A, Wang D, Jowett S, Frew E, Day E, Bayliss S, Roberts T, Burls A. Oral Naltrexone as a Treatment for Relapse Prevention in Formerly Opioid Dependent Drug Users: A Systematic Review and Economic Evaluation. Health Technology Assessment, 2006;11(6) 1-85

 

Day E, Best D, Ison J, Keaney F, Strang J, Buntwal, N. Do Psychiatrists Make a Difference? Impact of Levels of Medical Input to the Range of Treatment Provided in In-patient Drug Detoxification Services – Drugs: Education, Prevention & Policy, 2006;13(6): 577-585

 

Graham H, Copello A, Birchwood M, Orford J, McGovern D, Mueser K, Clutterbuck R, Godfrey E, Maslin J, Day E, Tobin D. A Preliminary Evaluation of Integrated Treatment for Co-existing Substance Use & Severe Mental Health Problems: Impact on Teams & Service Users. Journal of Mental Health, 2006;15(5) 577-591

 

Ison J, Day E, Fisher K, Pratt M, Hull M, Copello A. Self-Detoxification from Opioid Drugs. Journal of Substance Use, 2006;11(2): 81-88

 

Copello A, Williamson E, Orford J & Day E.Implementing and evaluating Social Behaviour and Network Therapy in Drug Treatment Practice in the UK: A Feasibility Study. Addictive Behaviors, 2006;31(5) 802-810

 

Day E, Eggen J, Ison J, Copello A, Fazil Q. Ethnicity and Attempts at Self-Detoxification From Opioid Drugs. Drugs: Education, Prevention & Policy, 2006;13(1): 93-103

                                                                                                                                                           

Webb K, Shepherd L, Day E, Masterton G & Neuberger J. Transplantation for Alcoholic Liver Disease: Report of a Consensus Meeting. Liver Transplantation, 2006;12: 301-305

 

Day E (Commentator) Rapid access to methadone improved entry and outcomes in heroin addicts awaiting methadone treatment. Evidence-Base Medicine, 2006;11(4):112

 

Best D, Day E & Keaney F. The future for inpatient drug treatment services in England – the need to increase more than just capacity (Editorial) Journal of Substance Use, 2005;10(4) 183-186

 

Huxley A., Copello A. & Day E. Substance misuse amongst people with learning disabilities: Is it time to develop integrated services? Journal of Learning Disability Practice, 2005;8: 14-17

 

George S, Georgiou G & Day E. Wernicke’s Encephalopathy and Tobacco-Alcohol Amblyopia Reversed by Multivitamin Supplementation. Journal of Substance Use, 2005;10(6): 403-406

 

Day E, Gaston R, Furlong E, Murali V & Copello A. UK Substance Misuse Treatment Workers’ Attitudes to Twelve-Step Self-Help Groups. Journal of Substance Abuse Treatment, 2005;29:321-327

 

Rajesh G & Day E. Aggression in drug-dependent in-patients. Psychiatric Bulletin, 2005;29(4):141-143

 

Day E, Ison J & Strang J. Inpatient versus outpatient detoxification for opioid dependence. In: The Cochrane Library, Issue 2, 2005, Oxford: Update Software

 

Day E & George S. (2005) The Management of Drug Misuse in Pregnancy. Advances in Psychiatric Treatment, 2005;11: 253-261

 

Day E. Reading about… self-help books on alcohol problems. Psychiatric Bulletin, 2004;28(3):109-110

 

Day E, Patel J & Georgiou G. A pilot study to evaluate a symptom-triggered front-loading detoxification technique for alcohol dependence Psychiatric Bulletin, 2004;28(11):407-410

 

Day E, Bentham P, Callaghan R, Kuruvilla T & George S. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol misuse. In: The Cochrane Library, Issue 1, 2004, Oxford: Update Software

 

Day E, Fisher K, Watson J, Al-Gommer O, McCormick T. The Role of Detoxification Using Methadone Reduction in a Drug Treatment Service. Journal of Substance Use, 2003;8(4):252-259

 

Orford J, Boulay S, Graves N, Copello A, Purser B & Day E. Gambling and Problem Gambling Amongst Clients, and Staff Attitudes, in an Alcohol and Drug Problems Treatment Service in the English Midlands. Journal of Gambling Studies, 2003;3(2): 171-181

 

Kelly B & Day E. World Congress of Psychiatry: report from Fellowship and Young Participants’ programme. Irish Psychiatrist, 2003;4:131-132

 

Crome IB & Day E. A Comparison of UK and USA Addiction Research: an E-mail Survey. Drugs: Education, Prevention & Policy, 2003;10(3):281-284

 

Georgiou G, Webb K, Griggs K, Copello A, Neuberger J & Day E. A Pilot study of a Psychosocial Intervention for Patients With Alcohol Related Liver Disease Undergoing Liver Transplantation. Liver Transplantation. 2003;9(7): 772-775

 

Day E, Wilkes S & Copello A. Spirituality and Addiction: Not Everyone’s Cup of Tea. BMJ, 2003;326:881

 

Day E, Porter L, Clarke A, Allen D, Moselhy H & Copello A. Drug Misuse in Pregnancy: The Impact of a Specialist Treatment Service. Psychiatric Bulletin, 2003;27: 99-101

 

Day E & Smith I. Addiction & Literature. Advances in Psychiatric Treatment, 2003;9: 62-68

 

Vassilas C, Tadros G & Day E. The Research Day: a suitable case for treatment? Psychiatric Bulletin, 2002;26: 313-314

 

Day E, Grimmer C & Lloyd A. Psychiatry Training in Europe: A Brief History of the European Federation of Psychiatric Trainees Psychiatric Bulletin, 2002;26: 152-154

 

Moselhy HF, Georgiou G, Kahn A & Day E. A Survey of Amphetamine Prescribing by Drug Services in the East and West Midlands. Psychiatric Bulletin, 2002;26: 61-62

 

Day E & Bolton J. The Collegiate Trainees' Committee. Psychiatric Bulletin, 2002;26: 22-23

 

Day E & Ramchandani P. Place and purpose of research training. Psychiatric Bulletin, 2000;24: 314-315.

 

Day E & Brown N. The Role of the Educational Supervisor: A Questionnaire Survey. Psychiatric Bulletin, 2000;24: 216-218.

 

Laidlaw J, Bentham P, Khan G, Staples V, Dhariwal B, Coope B, Day E, Fear C, Marley C & Stemman J.  A comparison of Stimulus Dosing Methods for Electroconvulsive Therapy. Psychiatric Bulletin, 2000;24:184-187.

 

Crome IB & Day E. Substance Misuse and Dependence: Older People Deserve Better Services. Reviews in Clinical Gerontology, 1999;9:327-342

 

Brown N & Day E. The Alternative Journal Club. Psychiatric Bulletin, 1999;23:691-692.

 

Day E, Arcelus J, Kahn A. The Perceived Role of Psychiatrists in Managing Substance Misuse: A Questionnaire Survey. Psychiatric Bulletin, 1999;23:667-670.

 

Greening J, Bentham P, Stemman J, Staples V, Ambegaokar S, Upthegrove R and Day E. The effect of structured consent on recall of information pre- and post-ECT: a pilot study. Psychiatric Bulletin, 1999;23:471-474.

 

Day E, Kahn A, Georgiou G. Misusers may receive methadone from drug centres and GPs simultaneously. BMJ, 1999;318:395-396.

 

Books

 

Clark T, Day E & Fergusson E (2011). Core Clinical Cases in Psychiatry, 2nd Edition. Hodder Arnold, London

 

Day E (Editor) (2007) Clinical Topics in Addiction (2nd Edition). RCPsych Publications, London

 

 

Book Chapters

 

Hull M & Day E. (2018) Drug Use Disorders. In Gask L., Kendrick T, Peveler R & Chew-Graham A. Primary Care Mental Health (pp236-250). Cambridge University Press, London.

 

Day E (2017) Building Bridges to Positive Social Identities: The Social Network Diagram and Opiate Substitution Treatment. In Buckingham S.A. & Best D. (eds) Addiction, Behavioural Change and Social Identity. Routledge, Abingdon

 

Day E & Jheeta M.  (2016) Management of Alcohol Use Disorders in the UK. In Mistral W. (ed.) Action on Addiction: Integrated Approaches to Drug and Alcohol Problems. Routledge, London

 

Copello A, Mahmood M & Day E. (2016) Alcohol and Other Drug Problems. In Carr A. & McNulty M. (eds) The Handbook of Adult Clinical Psychology: An Evidence Based Approach (pp791-848). Routledge, London

 

Tas B & Day E. (2016) Pharmacology and physiological mechanisms of opioid overdose and reversal. In Strang J & McDonald R (eds) Preventing Opioid Overdose Deaths with Take-home Naloxone. EMCDDA Insights Series Volume 20, EMCDDA, Lisbon

 

Chawla R, Day E & Gerada C. (2013) Drug Misuse, Dual Diagnosis and Wider Co-Morbid Illness. In Wright N, Gerada C & Sheard L (eds) RCGP Guide to The Management of Substance Misuse in Primary Care (Second Edition). Royal College of General Practitioners, London

 

Day E & Khurmi S. (2012) Alcohol. In Gray D & Cormac I (eds) Essentials of Physical Health in Psychiatry. RCPsych Publications, London

 

Day E & Khurmi S. (2012) Drugs. In Gray D & Cormac I (eds) Essentials of Physical Health in Psychiatry. RCPsych Publications, London

 

Best D & Day E. (2010) Applied Research Methods. In Miller PG, Strang J & Miller PM (eds.) Addiction Research Methods. Wiley-Blackwell

 

Day E & Turner E. (2010) Drug Misuse in Women. In Kohen, D, (ed) Oxford Textbook of Women’s Mental Health. Oxford University Press

 

Roche J, Gilvarry E & Day E. (2010) Alcohol Misuse in Women. In Kohen, D, (ed) Oxford Textbook of Women’s Mental Health. Oxford University Press

 

Day E & Smith I (2009). Literary and biographical perspectives on substance use. In Oyebode F (ed) Mindreadings: Literature and Psychiatry. RCPsych Publications.

 

Ziedonis DM, Day E, O’Hea EL, Krejci J, Berman JA, Smelson D. (2008) Treatment of Co-Occurring Psychiatric and Substance Use Disorders. In: Tyrer P & Silk KR (eds) Cambridge Textbook of Effective Treatments in Psychiatry. Cambridge University Press.

 

Day E & Cooper A. Psychoactive Substance Use and Addiction. (2007) In: The Human Brain and its Disorders. Edited by Richards D., Clark T. & Clarke C.

 

Best D, George S & Day E (2007). The Development of the Drug Treatment System in England. In Day E (ed) Clinical Topics in Addiction. RCPsych Publications.

 

Day E & Crome IB (2002). Physical Health Problems. In: Peterson T &  McBride A (eds) Substance Misuse, Theory and Practice: A Guide for Students. Routledge.

 

Day E, Georgiou G & Crome IB (2002). Pharmacological Management of Co-Morbidity. In: Graham H, Mueser K, Birchwood M & Copello A, (eds) Substance Misuse in Psychosis: Approaches to Treatment and Service Delivery. John Wiley & Sons.

 

Crome IB & Day E (2002). The Role of Outreach Work: the Example of Drug and Alcohol Abuse. In: Elder A, Holmes J (eds) Mental Health and Primary Care. Oxford University Press.

View all publications in research portal